Top Markets
#1 MowCat MowCat +48.94%
#2 Bermuda Shorts Bermuda Shorts +35.34%
#3 aPriori aPriori +21.46%
#4 Biconomy Biconomy +19.82%
#5 Derive Derive +19.62%
#6 Velvet Velvet +18.18%
#7 Quack AI Quack AI +17.21%
#8 Audiera Audiera +15.85%
#9 Perle Perle +15.57%
#10 Block Street Block Street +12.65%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Tissue Repair Ltd Tissue Repair Ltd

Tissue Repair Ltd

TRP
株式のランク #35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
株価
$0.05994921
最終同期: 2026-08-13
時価総額
$3.62M
変化（1日）
-1.16%
変化（1年）
-66.49%
国
AU
取引 Tissue Repair Ltd (TRP)

カテゴリー

Healthcare
Tissue Repair Ltd（TRP）の利益
2026 時点の利益 TTM: 0
Tissue Repair Ltd の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Tissue Repair Ltd の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE